Skip to main content
CDLX logo

CDLX · Cardlytics, Inc.

Track CDLX — free
$4.30 +0.04 (+0.94%) At close · Aug 20
Market Cap
$25.32M
Shares
5.89M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.30 Open$4.33 Day$4.17–4.40 Since split$3.52–5.41 Avg vol 30d48K Short int645K · 11.0% float · 16.0d Short vol50% Last earningsAug 5, 2026 DataJun 2026–Aug 2026 Filing10-Q · Aug 5

Raw chart and full-history price indicators begin at the captured split on Jun 8, 2026; bars on opposite sides are not compared.

The closing range begins at the captured split on Jun 8, 2026.

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Buy Momentum Limited Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 16 · calm Equity put/call 0.58
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 50-day avg −1%
      below
      RSI (14) 55
      neutral
      MACD trend Positive
      52-week position 41%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Limited
      Not enough data for a confident read.
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50/200-day averages unavailable
      Institutional flow Distributing
      -32% holders QoQ · +9 funds added
      Insider flow Distributing
      Net -$134.2K over 90 days · 100% sells
      Short interest Falling
      10.96% of float · ▼ -2.7% MoM · 16.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      42 holders — near 3-yr low, contrarian setup
      Squeeze score 76
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth −16%
      Y/Y
      EPS growth +50%
      Y/Y
      Free cash flow $8.8M
      Buyback $40.0M
      authorized
      Balance sheet $2.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 73%
      annualized · 1-yr
      Max drawdown −35%
      past year
      ATR 8.3%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 2 of last 2
      Latest guidance · from the Earnings Call filed Mar 31, 2024
      Billings · Q2 $115M – $126M
      Adjusted contribution · Q2 $40M – $45M
      Prior guidance period ended · from the 8-K filed May 7, 2026
      Billings · Q2 2026 $61M – $67M
      Revenue · Q2 2026 $35M – $40M
      Adjusted Contribution · Q2 2026 $20M – $23M
      Adjusted EBITDA · Q2 2026 $-2.7M – $1.3M
      Guided vs delivered · last 2 settled
      Revenue Q4
      guided $82M – $90M
      $89.17M In line
      Revenue Q3
      guided $75M – $84M
      $79.01M In line

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 5 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 50-day avg
      −1% Neutral
      RSI (14)
      55 Neutral
      MACD trend
      Positive Bullish
      52-week position
      41% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50/200-day averages unavailable
      Institutional flow Distributing
      -32% holders QoQ · +9 funds added
      Insider flow Distributing
      Net -$134.2K over 90 days · 100% sells
      Short interest Falling
      10.96% of float · ▼ -2.7% MoM · 16.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr low
      42 holders — near 3-yr low, contrarian setup
      Price context
      position in its range since split · 2026-06-08
      Range low $4 Now $4 · 41% Range high $5
      vs 50-day avg -1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted Net Loss non-GAAP -10.89M Six Months Ended June 30, 2026
      Adjusted Net Loss per share non-GAAP -$1.94 Six Months Ended June 30, 2026
      Cardlytics monthly qualified users 185.4M the second quarter of 2026
      Free Cash Flow non-GAAP -18.65M Six Months Ended June 30, 2026

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Advertising Agencies — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CDLX
      Cardlytics, Inc.
      this stock
      $25.32M -16.2% 11.0%
      APP
      AppLovin Corp
      $103.33B -54.2% +70.0% 23.7 3.6%
      OMC
      Omnicom Group Inc.
      $24.92B +7.8% +10.1% 9.5%
      QMMM
      QMMM Holdings Ltd
      $6.83B -3.9% 7.3%
      TTD
      Trade Desk, Inc.
      $6.26B -64.9% +18.5% 15.9 16.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      42
      % held
      44.6%
      Net QoQ
      +800.5K sh
      Top holder
      SUSQUEHANNA INTERNATIONAL…
      Held Float
      View
      Held by Funds
      Fund positions
      10
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      645.2K
      Days to cover
      16.0d
      Change
      -18.1K sh
      View
      Short Volume
      Short vol %
      50%
      As of
      Aug 20, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      106
      Value
      $384
      As of
      Jul 27, 2026
      View
      Off-Exchange
      Off-exchange %
      38.8%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$134.2K
      Buyers / Sellers
      0 / 2
      Buyers Sellers
      View
      Congressional Trades Buy
      Member
      David A Perdue , Jr
      Amount
      $100.0K–$250.0K
      Traded
      Mar 18, 2020
      View
      Financials
      Financials
      Revenue (FY)
      $233.3M
      Net income (FY)
      $-103.5M
      EPS diluted
      $-19.50
      View
      Buybacks
      Authorized
      $40.0M
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 5, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $26.9K
      Shares
      6.7K
      Filed
      Aug 18, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View
      Investor Relations
      Latest news
      Cardlytics Second Quarter 2026 Fi…
      Published
      Aug 5, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on Jun 8, 2026; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      CDLX +0.9% +11.7% +15.0%
      SPY -2.0% +3.3% +11.2% +2.1% +11.8%
      vs SPY +2.9% +8.4% +12.9%

      Capital returns

      Buyback program · as of Jun 30, 2022
      Authorized
      $40.00M
      Spent (derived)
      Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1666071 CUSIP 14161W303 13F (30d) 40 filings 40 filers Visit website Investor relations